ALPCO Diagnostics-医療機器分野:企業M&A・提携分析

◆英語タイトル:ALPCO Diagnostics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012908
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ALPCO Diagnostics (ALPCO) is a lifescience company that imports and distributes immunoassay based products. The company’s products include immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It also provides food additives, acute leukemia orientation tube, vitamins, anti bovine growth hormone, multi-epitope antibody, and others. ALPCO’s products are used for therapeutic areas including antibodies and antigens, bone metabolism, allergy and infectious disease, endocrinology, diabetes and obesity, toxicology and neurobiology. The company’s stellux is a chemiluminescent assay platform. It markets its products through a network of distributors located across the world. ALPCO is headquartered in Salem, New Hampshire, the US.

ALPCO Diagnostics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ALPCO Diagnostics, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ALPCO Diagnostics, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ALPCO Diagnostics, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ALPCO Diagnostics, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ALPCO Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ALPCO Diagnostics, Medical Equipment, Deal Details 10
Partnerships 10
Euro Diagnostica Enters Into Distribution Agreement With Alpco Diagnostics For Assay Portfolio 10
BioCat Enters Into Distribution Agreement With Alpco Diagnostics For ELISA Kits 11
WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 12
ALPCO Diagnostics – Key Competitors 13
ALPCO Diagnostics – Key Employees 14
ALPCO Diagnostics – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
ALPCO Diagnostics, Medical Equipment, Key Facts 2
ALPCO Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ALPCO Diagnostics, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ALPCO Diagnostics, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ALPCO Diagnostics, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ALPCO Diagnostics, Deals By Market, 2011 to YTD 2017 8
ALPCO Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Euro Diagnostica Enters Into Distribution Agreement With Alpco Diagnostics For Assay Portfolio 10
BioCat Enters Into Distribution Agreement With Alpco Diagnostics For ELISA Kits 11
WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 12
ALPCO Diagnostics, Key Competitors 13
ALPCO Diagnostics, Key Employees 14

★海外企業調査レポート[ALPCO Diagnostics-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Duke Energy Carolinas LLC-エネルギー分野:企業M&A・提携分析
    Summary Duke Energy Carolinas, LLC (Duke Energy Carolinas), a subsidiary of Duke Energy Corporation, is a regulated electric utility, which generates, transmits, distributes and sells energy. The company produces power from nuclear, coal, oil and gas, hydro, and solar sources. It is subject to the r …
  • DiaCarta Inc-医療機器分野:企業M&A・提携分析
    Summary DiaCarta Inc (DiaCarta) develops and commercializes molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation de …
  • Abbott Diagnostics:企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • Faes Farma SA (FAE):製薬・医療:M&Aディール及び事業提携情報
    Summary Faes Farma SA (Faes Farma) develops, manufactures and commercializes pharmaceutical products and raw materials. The company offers prescription drugs, generic drugs, food supplements, over-the-counter (OTC) medications, baby foods, skin-care treatment products. It exports raw-materials and f …
  • Evotec AG (EVT):医療機器:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Air Products and Chemicals Inc (APD)-石油・ガス分野:企業M&A・提携分析
    Summary Air Products and Chemicals Inc (Air Products) is an industrial gases company. It provides a portfolio of products, services, and solutions that include atmospheric, process and specialty gases, electronics and performance materials, and equipment. The company supplies oxygen, nitrogen, argon …
  • RIKEN-製薬・医療分野:企業M&A・提携分析
    Summary RIKEN is a research organization, which carries out research in basic and applied sciences. Its research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, laboratories and researc …
  • Tsumura & co (4540):製薬・医療:M&Aディール及び事業提携情報
    Summary Tsumura & co (Tsumura) is a traditional pharmaceutical products company, which undertakes the manufacturing and sale of Kampo extract intermediates and granular Kampo formulations. Its product portfolio includes a range of prescription Kampo products, other pharmaceuticals, over-the-counter …
  • Oil-Dri Corporation of America (ODC):企業の財務・戦略的SWOT分析
    Summary Oil-Dri Corporation of America (Oil-Dri) is a manufacturer and supplier of sorbent products. The company offers granular clay absorbents, universal absorbent products, oil only absorbents, haz mat, socks and boom, spill kits, sweeping compounds, and secondary containment products. Its univer …
  • City Developments Ltd:企業の戦略・SWOT・財務情報
    City Developments Ltd - Strategy, SWOT and Corporate Finance Report Summary City Developments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • McDermott International Inc (MDR):電力:M&Aディール及び事業提携情報
    Summary McDermott International Inc (MII) is a provider of integrated engineering, procurement, construction and installation (EPCI), front-end engineering and design (FEED) and module fabrication services for upstream field developments. It delivers fixed and floating production facilities, pipelin …
  • Koninklijke Ten Cate NV:企業の戦略的SWOT分析
    Koninklijke Ten Cate NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Harry Ramsden’s:企業の戦略・SWOT・財務分析
    Harry Ramsden's - Strategy, SWOT and Corporate Finance Report Summary Harry Ramsden's - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • EnerDel Inc:企業の戦略的SWOT分析
    EnerDel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cielo Wind Power LP:企業の戦略的SWOT分析
    Cielo Wind Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Heptares Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Heptares Therapeutics Ltd (Heptares) a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise S …
  • Stanwell Corp Ltd:企業の戦略的SWOT分析
    Stanwell Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • EarLens Corp:医療機器:M&Aディール及び事業提携情報
    Summary EarLens Corp (EarLens) is engaged in designing and manufacturing of hearing aid products for hearing impaired patients. Its lead product Earlens Hearing Aid is a hearing device that utilizes light to transmit sound. The device automatically adjusts to noisy environments and delivers the broa …
  • Wood Group Mustang Inc-石油・ガス分野:企業M&A・提携分析
    Summary Wood Group Mustang, Inc. (Wood Group Mustang), a subsidiary of John Wood Group PLC is an engineering management company. It provides engineering, procurement, and construction management (EPC) services to clients across diverse end markets. The company’s service portfolio comprises design an …
  • AnaptysBio Inc (ANAB):企業の財務・戦略的SWOT分析
    AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆